Target Oncology Centers Delee's CytoCatch platform integrates CTC isolation and automated staining with imaging analysis, aligning with hospital oncology labs pursuing liquid biopsy, early cancer detection, and therapy monitoring. Target large cancer centers, academic medical centers, and pathology departments for pilot programs and multi site deployments, offering bundled hardware, consumables, and cloud analytics, with emphasis on streamlined workflows and clinician ready reports.

CRO Partnerships The automated workflow and imaging analytics can be packaged as a scalable service for CROs conducting oncology trials. Propose joint development of standardized CTC assays, data dashboards, and regulatory grade reports to speed data delivery to sponsors, enabling co selling with pharma biotech customers.

Clinical Adoption Pathways Pursue integration into CLIA and CAP compliant labs and LIMS EMR workflows, offering service contracts, training, and cloud based data sharing. Pilot programs with early detection and treatment monitoring can demonstrate ROI and drive adoption in hospital networks.

Competitive Positioning Differentiate on automation, integrated imaging, and a compact solution that can be customized to lab workflows. Pursue partnerships with larger diagnostic and life science suppliers for co marketing or white labeling, and emphasize speed to results in oncologic decision making.

Recurring Revenue Develop a diversified revenue model including device maintenance, consumables, and software subscriptions for cloud analytics. Offer tiered service packages for labs of different sizes and consider reseller channels to accelerate market reach beyond California.